PUMA BIOTECHNOLOGY, INC. (PBYI) insider trading

By person

11 insiders · 17 transactions

71.1×

Alan H. Auerbach holds 71.1 times base salary in stock. $66.25M of shares against $931.33K in salary for 2025.

Salary from the company's own proxy. The shares are what Alan H. Auerbach last reported holding, valued at $9.12, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Alan H Auerbach

President and CEO

—

$568.93K (3) scheduled

−$568.93K

7,261,671

14.07%

$66.25M

+2.8%

Alessandra Cesano

Director

—

$566.99K (1) scheduled

−$566.99K

56,700

0.1098%

$517.27K

+5.0%

Adrian Senderowicz

Director

—

$194.31K (1) scheduled

−$194.31K

27,000

0.0523%

$246.32K

0.0%

Jay M Moyes

Director

—

$158.80K (1) scheduled

−$158.80K

58,322

0.1130%

$532.07K

+20.7%

Maximo F Nougues

Chief Financial Officer

—

$141.74K (3) scheduled

−$141.74K

230,637

0.4468%

$2.10M

+41.9%

Troy Edward Wilson

Director

—

$123.25K (2) scheduled

−$123.25K

55,300

0.1071%

$504.50K

+98.2%

Douglas M Hunt

See Remarks

—

$122.60K (3) scheduled

−$122.60K

196,841

0.3813%

$1.80M

+47.7%

Michael Patrick Miller

Director

—

$97.23K (1)

−$97.23K

81,000

0.1569%

$738.96K

+72.3%

Allison Dorval

Director

—

$83.58K (1) scheduled

−$83.58K

90,780

0.1759%

$828.19K

+51.3%

Brian M Stuglik

Director

—

$58.31K (1) scheduled

−$58.31K

113,858

0.2206%

$1.04M

+49.7%

Jeffrey Jerome Ludwig

Chief Commercial Officer

—

156,792

0.3037%

$1.43M

+32.4%

PUMA BIOTECHNOLOGY, INC.

What the insiders did Mostly scheduled

By person